Jardines HC Marbella 2018

Bizjak da Fonseca, Tina

Ginecología y Obstetricia
Especialista en suelo pélvico

Dra. Tina Bizjak

Especialidad

Ginecología y Obstetricia, especialista en suelo pélvico

Nº Colegiado

292913216

Idiomas

Español, inglés, alemán, esloveno, portugués, croato, serbo, bosnio

Formación

2004 – 2011: Licenciada en Medicina por la Facultad de Medicina de la Universidad de Graz, Austria.

 

2012 – 2017: Residencia en obstetricia y ginecología. University Medical Center Maribor, Eslovenia.

 

2015: ESGE Bachelor in Endoscopy Certificate European Society for Gynaecological Endoscopy.

 
2015-2021: Doctorado en genética del prolapso uterlino. Medical Faculty Maribor, Eslovenia.

Cronología de trabajo

Actualmente, especialista en ginecología y obstetricia en HC Marbella International Hospital.

 

2023: Especialista en ginecología y obstetricia en Quirón Málaga.

 

2017-2023: Especialista en ginecología y obstetricia. Division of Gynecology and Perinatology, University Medical Center Maribor, Eslovenia.

 

Desde 2019: Miembro de Comisión de Derechos del Paciente. Ministry of Health of the Republic of Slovenia.

 

2013-2017: Residente médico en ginecología y obstetricia, University Medical Center Maribor, Eslovenia.

 

2012-2013: Médico de cabecera, Health Center, Ljutomer, Ljutomer, Eslovenia.

Publicaciones

 
Revistas médicas
 

  • Bizjak T et al. Polymorphism on chromosome 20p13 near the IDH3B gene is associated with uterine prolapse. European Journal of Obstetrics & Gynecology and Reproductive Biology. [Online ed.]. 2020
  • KovaC“ V, Reljk“ M, Bizjak T. Causes of massive vulvar edema in patients with severe ovarian hyperstimulation syndrome : a case report and literature review. The American journal of case reports. 2019
  • Bizjak T et al. Prevalence and Risk Factors of Uterine Fibroids in North-East Slovenia. Gynecology & obstetrics. Jan. 2016
  • Pakiz M.2, Bizjak T et al. Prevention of venous thromboembolism in gynecologic surgery. Zdravni§ki vestnik: 2015.
  • Takac I, Bizjak T et al. Questionnaire of the management of the victim of sexual abuse. Zdravni§ki vestnik: 2013.
  • Takat“ I, Bizjak T et al. Reproductive health care among incarcerated women. Medicinski razgledi: 2012.
  • Bizjak T et al. American trypanosomiasis – Chagas disease. Medicinski razgledi: 2011.
  • Tchernitchin A et al. Effects of acute exposure to cadmiun on response to estrogen in the prepuberal rat uterus. Revista Chilena de Pediatria: 2008.

 
 

Presentaciones en Congresos
 

  • Bizjak T, But I. The SNP rs1810636 associated with uterine prolapse could improve the selection of the best surgical approach in these patients. ESGE 32th Annual Congress, Brussels 2023.
  • Bizjak T, But I. Uterine fibroids in North-East Slovenia. ESGE 30th Annual Congress , Rome 2021.
  • Bizjak T. 10-year retrospective study of outcomes of all three types of laparoscopic hysterectomy. ESGE 29th Annual Congress, Lisbon 2020.
  • Bizjak T. The SNP rs1810636 associated with uterine prolapse could improve the selection of the best surgical approach in these patients. ESGE 28th Annual Congress. Thessaloniki, Greece 2019.
  • Takat“ I, Bizjak T, Arko D. Sexual assault. Maribor, Slovenia 2018.
  • Bizjak, T, Ferreira H. Laparoscopic ureteroureterostomy vs. ureteroneocystostomy in the management of intrinsic ureteral endometriosis: presentation on AAGL Global Endometriosis Summit, Reykjavík, Iceland, July 20-21, 2017.
  • Paki2, M, Bizjak T. Prevention of venous thromboembolism in gynecologic surgery.. Maribor 2016.
  • Bizjak T, But I. Genetic risk factors for uterine prolapse. Gospi¿, Croatia 2016.
  • Relji¿ M, Pukl Batisti¿ J, Bizjak T. Does hysteroscopy with local endometrial injury improve implantation in patients with recurrent implantation failure?., Ljubljana, Slovenia 2015.
  • Bizjak T et al. A case report of primary peritonitis post-partum. Bassano del Grappa, Italy 2015.
  • Paki2 M, Bizjak T et al. Biopsy of sentinel lymphnode in treatment of endometrial carcinoma – our first experiences. Maribor 2015.
  • Kuder L, Bizjak T. Effectiveness of time prenatal diagnosis of vasa previa: a report of three cases; Ultrasound in Obstetrics and Gynecology Congress, Barcelona 2014
  • Bizjak B, Bizjak T. New Oral Anticoagulants in Our Clinical Practice, Thrombosis Research, Thrombosis Research 2014
  • Takat“ I, Bizjak T et al. Recommendations for the management of a rape victim. Ljubljana 2013
  • Bizjak B, Lokar L, Bizjak T. Mild haemolytic disease of fetus and newborne due to anti- G and -C. Vox Sanguinis 2013
  • Bizjak B, Bizjak T. Providing compatible blood to patients with alloantibodies in NE Slovenia. Pocketrtek, Slovenia 2012

 
 

Capítulos de libros
 

  • BIZJAK, Tina. Sledenje, pre2ivetje in prognoza bolnic po zdravljenju raka jajcevodov. V: TAKAC, Iztok (ur.), ARKO, Ginekolo§ka onkologija. 1. izd. Maribor: Univerzitetna zaloha Univerze, 2020
  • TAKAC, Iztok, BIZJAK, Tina, ARKO, Darja. Obrada 2rtve spolnog zlostavljanja u Sloveniji : upitnik i uputa. V: et al. Forenziéka ginekologija i perinatologija. Zagreb: Medicinska naklada: Hrvatsko katoliéko sveudli§te, 2018
  • TAKAC, Iztok, BIZJAK, Tina. Spolna zloraba. In: TAKAC, Iztok (ur.), et al. Ginekologija in perinatologija. 1. izd. Maribor: Medicinska fakulteta, 2016.

 
 

Reseñas de artículos
 

  • Stillbirths in a tertiary facility offering free maternity services in southwest Nigeria: a one-year review, African Journal of Medical and Health Sciences, 2021
  • Advances in molecular mechanisms of pelvic organ prolapse:a narrative review, Review Article, International Urogynecology Journal, 2021
  • Sonographische Verlaufsbeobachtung des Wachstums von Myomen bei nichtbehandelten Frauen und deren Einflussfaktoren, Geburtshilfe und Frauenheilkunde, 2022
  • Myxoid liposarcoma of the vulva: A rare malignancy mimicking benign vulvar mass, American Journal of Case Reports, 2022

 
 

Tel.: +34 952 908 628
+34 609 148 799

952908898 Onkologie
951829978 Bildgebende Diagnostik
951829947 Gynäkologie
952908897 Fertilitäts-Zentrum
951829947 Physiotherapie

 

     

     

    Quiero recibir mails con ofertas y novedades sobre este y otros servicios *

    No

     

    Responsable: HC Hospitales, S.L. Finalidad: Gestionar la solicitud de la cita. Mandarte información vía newsletter, si lo aceptas. Finalidad: Gestionar la solicitud de la cita. Mandarte información vía newsletter, si lo aceptas. Duración: Los datos se eliminan en cuanto se te da la información, salvo que contrates o que nos pidas que te contactemos a futuro. En el newsletter, en cuanto te borras del mismo. Destinatarios: No cedemos tus datos a nadie. Derechos: A acceder, rectificar, y suprimir tus datos, y otros derechos explicados en la información adicional: https://clientes.prodat.es/privacidad/MLG/HCMARBELLA

     

    Persönliche Patientenbetreuung

    Patienten-Betreuung

    Spezialisten in der HC

    Abonnieren Sie unseren Newsletter

    Abonnieren Sie unseren Newsletter